<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-94136</identifier>
<setSpec>0212-1611</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Correlation between serum content of the main COPs (cholesterol oxidationproducts) from autoxidation and cardiovascular risk factors</dc:title>
<dc:description xml:lang="en">Background/aims: Risk factors for cardiovascular disease (CVD) have been proven to be associated with an increased oxidative stress. Several studies have considered cholesterol oxidation products (COPs) as specific in vivo markers of oxidative stress. The aim of this study was to investigate the association between the levels of COPs derived from autoxidation processes and established cardiovascular risk factors, comparing the levels of serum COPs in subjects with or without showing values out of the reference ranges. Methods: It was a cross-sectional study in which 88 subjects were recruited and individual and total COPs from autoxidation origin was analyzed in serum by GC-MS. The simultaneous correlation of COPs with different CVD risk factors have been analyzed. Results and discussion: A great variability of total COPs concentrations were found. Subjects presented total COPs values from 0.091 to 2.052 &amp;#956;g/mL. Total COPs were significantly higher (p &lt; 0.05) in patients with hyper-triglycerolemia, hypertension, diabetes and overweight/ obesity status compared to those subjects who did not present those CVD risk factors. Moreover, 7&amp;#945; and 7&amp;#946; hydroxycholesterol and 7-ketocholesterol were significantly higher (p &lt; 0.05) in patients with hypertension and diabetes. No significant differences in total COPs were found between patients with and without hypercholes-terolemia. Conclusions: The obtained results showed that the analyzed COPs correlate well with at least 4 out of 6 risk factors of development of CVD (AU)</dc:description>
<dc:creator>Varo, N</dc:creator>
<dc:creator>Restituto, P</dc:creator>
<dc:creator>Menéndez-Carreño, M</dc:creator>
<dc:creator>Ansorena, D</dc:creator>
<dc:creator>Mugueta, C</dc:creator>
<dc:creator>Astiasarán, I</dc:creator>
<dc:language>en</dc:language>
<dc:description xml:lang="es">Introducción: Se ha demostrado que los factores de riesgo cardiovascular están estrechamente asociados con un elevado nivel de estrés oxidativo. Varios estudios consideran a los productos de oxidación del colesterol (COPs) como marcadores específicos in vivo de estrés oxidativo. El objetivo de este trabajo fue estudiar la asociación entre los niveles de COPs derivados de procesos de autooxidación de colesterol y factores de riesgo cardiovascular, comparando el contenido sérico de COPs en sujetos afectados o no por dichos factores. Métodos: Se trata de un estudio transversal en el que se reclutaron 88 personas a las que se analizó el perfil de óxidos de colesterol en suero procedentes de autooxidación, por cromatografía de gases-espectrometría de masas. Se valoró la correlación de los niveles de COPs con diferentes factores de riesgo cardiovascular. Resultados y discusión: Se encontró una gran variabilidad en el contenido en COPs totales, observándose valores entre 0,091 y 2,052 &amp;#956;g/mL. COPs totales fueron significativamente superiores (p &lt; 0,05) en pacientes con hipertrigliceridemia, hipertensión, diabetes y sobrepeso/ obesidad con respecto a aquellos sujetos que no presentaron estos factores de riesgo cardiovascular. Además, 7&amp;#945; y 7&amp;#946;-hidroxicolesterol y 7-ketocolesterol mostraron valores mayores (p &lt; 0,05) en pacientes con hipertensión y diabetes. No se observaron diferencias en COPs totales entre pacientes con y sin hipercolesterolemia. Conclusiones: Los resultados de este estudio mostraron que los COPs analizados presentan altos niveles de correlación con, al menos, 4 de 6 factores de riesgo cardiovascular considerados (AU)</dc:description>
<dc:source>Nutr Hosp;26(1): 144-151, ene.-feb. 2011. ilus, tab</dc:source>
<dc:identifier>ibc-94136</dc:identifier>
<dc:title xml:lang="es">Correlación entre los productos de oxidación de colesterol (COPs) formados por autooxidación y factores de riesgo cardiovascular</dc:title>
<dc:subject>^d9951^s22012</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d51841</dc:subject>
<dc:subject>^d2834^s22044</dc:subject>
<dc:subject>^d50504^s22027</dc:subject>
<dc:subject>^d2359^s22032</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d3942</dc:subject>
<dc:subject>^d23686^s22012</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:type>article</dc:type>
<dc:date>201102</dc:date>
</metadata>
</record>
</ibecs-document>
